Great West Life Assurance CO Tricida, Inc. Transaction History

Great West Life Assurance CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	BUY	$8.51 - $13.6 $15,845 - $25,323	1,862 New	1,862 $19,000
Q2 2022 Aug 09, 2022	BUY	$7.31 - $11.85 $13,611 - $22,064	1,862 New	1,862 $18,000
Q2 2021 Aug 11, 2021	SELL	$3.95 - $5.41 $10,479 - $14,352	-2,653 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$8.56 - $26.93 $22,709 - $71,445	2,653 New	2,653 $24,000
Q3 2020 Nov 13, 2020	SELL	$8.56 - $26.93 $22,709 - $71,445	-2,653 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$21.21 - $31.55 $28,145 - $41,866	1,327 Added 100.08%	2,653 $73,000
Q4 2019 Feb 11, 2020	BUY	$29.6 - $43.71 $39,249 - $57,959	1,326 New	1,326 $50,000
Q3 2019 Oct 25, 2019	SELL	$29.87 - $42.22 $61,442 - $86,846	-2,057 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$31.16 - $39.46 $33,029 - $41,827	-1,060 Reduced 34.01%	2,057 $0
Q4 2018 Feb 12, 2019	BUY	$23.57 - $32.33 $73,467 - $100,772	3,117 New	3,117 $71,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.